XML 13 R2.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Mar. 31, 2021
Dec. 31, 2020
ASSETS    
Cash and cash equivalents $ 20,842,782 $ 9,883,796
Grant funds and other receivables 182,663
Prepaid expenses and other current assets 118,430 168,689
Total current assets 20,961,212 10,235,148
Property and equipment, net 143,224 147,741
Deposits 11,010 11,010
Total assets 21,115,446 10,393,899
Current liabilities:    
Accounts payable 232,482 267,702
Accrued expenses 36,623 359,281
Current portion of notes payable 182,844 183,326
Total current liabilities 451,949 810,309
Note payable, net of current portion 12,157 14,738
Total liabilities 464,106 825,047
Commitments (Note 8)
Stockholders’ equity:    
Common stock, $.001 par value; Authorized shares – 600,000,000; Issued and outstanding shares – 6,315,467 and 3,834,095 at March 31, 2021 and December 31, 2020, respectively 6,315 3,834
Additional paid-in capital 67,937,289 55,294,504
Accumulated deficit (47,368,359) (45,805,581)
Total stockholders’ equity 20,651,340 9,568,852
Total liabilities and stockholders’ equity 21,115,446 10,393,899
Series B Convertible Preferred Stock [Member]    
Stockholders’ equity:    
Preferred Stock, $.01 par value: Authorized shares – 10,000,000: Series B convertible preferred stock, $1,000 stated value; Authorized shares – 10,000,000; 100 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively $ 76,095 $ 76,095